Renvela and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Renvela (sevelamer carbonate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Pantoprazole, and have Pain.

The phase IV clinical study analyzes which people have Fall when taking Renvela. It is created by eHealthMe based on reports of 10,884 people who have side effects when taking Renvela from the FDA, and is updated regularly.

What is Renvela?

Renvela has active ingredients of sevelamer carbonate. eHealthMe is studying from 10,923 Renvela users. Check the latest studies of Renvela.

What is Fall?

Fall is found to be associated with 3,237 drugs and 3,759 conditions by eHealthMe. Check the latest studies of Fall.

On Jul, 21, 2026

10,884 people reported to have side effects when taking Renvela.
Among them, 154 people (1.41%) have Fall.

Among these 154 people:

* Approximation only. Some reports may have incomplete information.

Do you take Renvela and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Renvela:

Renvela (10,923 reports)

Fall treatments and more:

Fall (403,513 reports)

How severe was Fall and when was it recovered:

Fall in Renvela

Expand to all the drugs that have ingredients of sevelamer carbonate:

Fall and drugs with ingredients of sevelamer carbonate (84 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Renvela:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,237 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,759 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sevelamer carbonate (the active ingredients of Renvela) and Renvela (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.